A new regimen of MESNA (2-mercaptoethanesulfonate9 effectively prevents cyclophosphamide-induced hemoorrhagic cystitis in bone marrow transplant recipients.
収録刊行物
-
- Transplant Proc.
-
Transplant Proc. 32 596-, 2000